Skip to content
Screener

FreeCast, Inc. CAST Cash & Equivalents

Cash & Equivalents at other companies

U.S. Bancorp logo
U.S. BancorpUSB
$48.42B-3.2%
BK
BKBK
$9.49B+12.8%
Polaryx Therapeutics, Inc.
 logo
Polaryx Therapeutics, Inc. PLYX
$3.08M+1,132%
Veradermics
 logo
Veradermics MANE
$168.41M+419%
Schering-Plough logo
Schering-PloughSGP
$238.9M+312%
Curtiss-Wright logo
Curtiss-WrightCW
$343.45M+51.7%

Other financials

Income statement

See full
Revenue$92.9K-35.4%
Gross profit$58.5K+16.6%
Operating income-$4.4M-33.7%
Net income-$4.5M-34.1%
EPS (diluted)-$0.11-22.2%

Balance sheet

See full
Total debt$313.2K
Total equity-$7.0M-115%
Total assets$1.1M

Valuation

See full
Market cap$58.52M-52.7%
Enterprise value$58.72M

Returns & leverage

See full
Return on equity264.6%
Debt / equity-0×
Current ratio0.1×

Where this comes from

Reported directly by FreeCast, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Cash.

The source filing: FreeCast, Inc. ’s 10-Q, filed May 15, 2026. Open the filing →

Filed
May 14, 2026, 8:00 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001213900-26-056942

FAQ

What is FreeCast, Inc. 's cash & equivalents?
FreeCast, Inc. (CAST) reported cash & equivalents of $119.3K in Q1 2026.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about FreeCast, Inc. 's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude